Skip to content

TMO

Thermo Fisher Scientific Inc.

Revenue by segment

2025, ended Dec 31, 2025

Earlier:

Segments by fiscal year

Segments by fiscal year
Line, in USD202520242023202220212020201920182017201620152014201320122011201020092008
Laboratory Products and Biopharma Services23.8B23.0B22.9B22.3B14.9B12.2B10.6B10.0B7.8B6.7B6.4B6.6B6.4B—————
Life Sciences Solutions8.8B8.2B8.5B11.6B15.6B12.2B6.9B6.3B5.7B5.3B4.8B4.2B713M659M————
Analytical Instruments7.35B7.27B7.10B6.44B6.07B5.12B5.52B5.47B4.82B3.67B3.21B3.25B3.15B3.11B3.74B3.24B2.92B4.47B
Specialty Diagnostics4.60B4.45B4.32B4.60B5.66B5.34B3.72B3.72B3.49B3.34B3.24B3.34B3.19B2.96B2.47B2.15B2.15B—
Segment Reconciling Items2.03B1.89B1.83B———————————————
Elimination of intersegment revenues−2.03B−1.89B−1.83B—−3.01B−2.66B−1.15B−1.14B−0.94B−0.77B−0.63B−0.50B−0.37B−0.33B−0.48B−0.47B−0.40B—
—————————————6.10B5.83B5.47B5.24B6.03B
Total44.6B42.9B42.9B44.9B39.2B32.2B25.5B24.4B20.9B18.3B17.0B16.9B13.1B12.5B11.6B10.4B9.9B10.5B